New Zealand
Tuberculosis profile
Population  2013 4.5 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) <0.01 (<0.01–<0.01) 0.14 (0.14–0.14)
Mortality (HIV+TB only) 0 (–) 0 (–)
Prevalence  (includes HIV+TB) 0.43 (0.19–0.77) 9.5 (4.1–17)
Incidence  (includes HIV+TB) 0.33 (0.3–0.36) 7.3 (6.7–8)
Incidence (HIV+TB only) <0.01 (<0.01–<0.01) 0.11 (0.07–0.21)
Case detection, all forms (%) 82 (76–89)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 0.9 (0.11–3.2) 17 (2.1–48)
MDR-TB cases among notified pulmonary
TB cases
1 (0–5) 2 (0–5)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 125   6
Pulmonary, clinically diagnosed 15   0
Extrapulmonary 125   1
       
Total new and relapse 272    
Previously treated, excluding relapses 5    
Total cases notified 277    
Among 272 new and relapse cases:
10 (4%) cases aged under 15 years; male:female ratio: 1.1
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 3 (2%) 0 (0%) 3
Laboratory-confirmed RR-/MDR-TB cases     3
Patients started on MDR-TB treatment     2
TB/HIV 2013 Number (%)
TB patients with known HIV status 195 (70)
HIV-positive TB patients 0 (0)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New and relapse cases registered in 2012 81
Previously treated cases, excluding relapse, registered in 2012 80
HIV-positive TB cases, all types, registered in 2012 100
RR-/MDR-TB cases started on second-line treatment in 2011 50
XDR-TB cases started on second-line treatment in 2011  
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2014  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-05-25 Data: www.who.int/tb/data